6.
Broeks M, van Karnebeek C, Wanders R, Jans J, Verhoeven-Duif N
. Inborn disorders of the malate aspartate shuttle. J Inherit Metab Dis. 2021; 44(4):792-808.
PMC: 8362162.
DOI: 10.1002/jimd.12402.
View
7.
Huang C, Bian J, Cao Q, Chen X, Pollock C
. The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease. Int J Mol Sci. 2021; 22(4).
PMC: 7913536.
DOI: 10.3390/ijms22041525.
View
8.
Schumann A, Brutsche M, Havermans M, Grunert S, Kolker S, Gross O
. The impact of metabolic stressors on mitochondrial homeostasis in a renal epithelial cell model of methylmalonic aciduria. Sci Rep. 2023; 13(1):7677.
PMC: 10175303.
DOI: 10.1038/s41598-023-34373-8.
View
9.
Aranda-Rivera A, Cruz-Gregorio A, Aparicio-Trejo O, Pedraza-Chaverri J
. Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases. Biomolecules. 2021; 11(8).
PMC: 8391472.
DOI: 10.3390/biom11081144.
View
10.
Guenzel A, Hofherr S, Hillestad M, Barry M, Weaver E, Venezia S
. Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing. Mol Ther. 2013; 21(7):1316-23.
PMC: 3708067.
DOI: 10.1038/mt.2013.68.
View
11.
Manoli I, Sysol J, Epping M, Li L, Wang C, Sloan J
. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. JCI Insight. 2018; 3(23).
PMC: 6328030.
DOI: 10.1172/jci.insight.124351.
View
12.
Bhatia D, Choi M
. The Emerging Role of Mitophagy in Kidney Diseases. J Life Sci (Westlake Village). 2020; 1(3):13-22.
PMC: 7041910.
DOI: 10.36069/jols/20191203.
View
13.
Gallego-Villar L, Perez-Cerda C, Perez B, Abia D, Ugarte M, Richard E
. Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia. J Inherit Metab Dis. 2012; 36(5):731-40.
DOI: 10.1007/s10545-012-9545-3.
View
14.
Behringer S, Wingert V, Oria V, Schumann A, Grunert S, Cieslar-Pobuda A
. Targeted Metabolic Profiling of Methionine Cycle Metabolites and Redox Thiol Pools in Mammalian Plasma, Cells and Urine. Metabolites. 2019; 9(10).
PMC: 6836102.
DOI: 10.3390/metabo9100235.
View
15.
Hannibal L, Theimer J, Wingert V, Klotz K, Bierschenk I, Nitschke R
. Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease. Front Endocrinol (Lausanne). 2020; 11:579981.
PMC: 7719825.
DOI: 10.3389/fendo.2020.579981.
View
16.
de Keyzer Y, Valayannopoulos V, Benoist J, Batteux F, Lacaille F, Hubert L
. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res. 2009; 66(1):91-5.
DOI: 10.1203/PDR.0b013e3181a7c270.
View
17.
Du F, Yu Q, Yan S, Hu G, Lue L, Walker D
. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease. Brain. 2017; 140(12):3233-3251.
PMC: 5841141.
DOI: 10.1093/brain/awx258.
View
18.
Longo N, Sass J, Jurecka A, Vockley J
. Biomarkers for drug development in propionic and methylmalonic acidemias. J Inherit Metab Dis. 2022; 45(2):132-143.
PMC: 9303879.
DOI: 10.1002/jimd.12478.
View
19.
Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D
. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biol. 2016; 11:297-311.
PMC: 5196243.
DOI: 10.1016/j.redox.2016.12.022.
View
20.
Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y
. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther. 2024; 9(1):50.
PMC: 10904817.
DOI: 10.1038/s41392-024-01756-w.
View